Institutional investors purchased a net $4.9 million shares of BIOC during the quarter ended September 2017. This may signal that the smart money is gaining interest in this company as the 13.05% of the shares outstanding that institutional investors hold is among the lowest in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
SABBY CAPITAL LLC Bought 2.4 Million shares of Biocept Inc
HEIGHTS CAPITAL MANAGEMENT, INC. Bought 1.4 Million shares of Biocept Inc
CITY NATIONAL ROCHDALE LLC Bought 1.1 Million shares of Biocept Inc